| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT07682961 Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in… |
Trial sites expanded: 3 -> 19 locations |
| 2026-08-15 | NCT07708727 Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People… |
Recruitment opened |
| 2026-08-15 | NCT07708727 Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People… |
Trial sites expanded: 0 -> 8 locations |
| 2026-08-14 | NCT06101342 Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for… |
date change Primary completion moved earlier: 2028-01 -> 2026-07-27 |
| 2026-08-12 | NCT07479797 Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants… |
Trial sites expanded: 10 -> 14 locations |
| 2026-08-12 | NCT06051617 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis |
Trial sites expanded: 205 -> 211 locations |
| 2026-08-11 | NCT07703878 A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid… |
Recruitment opened |
| 2026-08-11 | NCT07703878 A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid… |
Trial sites expanded: 0 -> 3 locations |
| 2026-08-07 | NCT07645287 A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically… |
Trial sites expanded: 3 -> 36 locations |
| 2026-07-31 | NCT07683000 Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults… |
Recruitment opened |
| 2026-07-31 | NCT07096193 Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta… |
Trial sites expanded: 19 -> 22 locations |
| 2026-07-29 | NCT07527858 Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults… |
Trial sites expanded: 8 -> 14 locations |
| 2026-07-28 | NCT05840224 Study of GS-4528 in Adults With Solid Tumors |
date change Primary completion pushed: 2026-07 -> 2026-10 |
| 2026-07-28 | NCT05840224 Study of GS-4528 in Adults With Solid Tumors |
date change Completion pushed: 2026-07 -> 2026-10 |
| 2026-07-24 | NCT07473778 Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention |
Trial sites expanded: 28 -> 31 locations |
| 2026-07-23 | NCT07682961 Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in… |
Recruitment opened |
| 2026-07-23 | NCT07682961 Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in… |
Trial sites expanded: 0 -> 3 locations |
| 2026-07-19 | NCT05006794 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as… |
critical Trial terminated |
| 2026-07-19 | NCT05006794 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as… |
critical why stopped: — → Sponsor decision to terminate |
| 2026-07-19 | NCT05006794 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as… |
Enrollment reduced: 145 -> 37 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-22 | NCT07719491 Study of GS-0415 and How It Works in People With HIV | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06337032 | A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have… | HIV-1-infection | Recruiting |
| Phase 3 | |||
| NCT05633654 | Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's… | Triple Negative Breast Cancer | Recruiting |
| NCT07683000 | Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults… | HIV-1-infection | Recruiting |
| NCT06051617 | Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis | Primary Biliary Cholangitis | Recruiting |
| NCT07479797 | Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants… | Relapsed or Refractory Large B-cell Lymphoma | Recruiting |
| NCT06801834 | Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously… | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Recruiting |
| NCT07682961 | Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in… | HIV Infections | Recruiting |
| NCT05382286 | Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's… | Triple Negative Breast Cancer | Active, Not Recruiting |
| NCT05840211 | Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With… | Locally Advanced or Unresectable Metastatic Breast Cancer | Active, Not Recruiting |
| NCT05371093 | Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With… | Relapsed/Refractory Follicular Lymphoma | Active, Not Recruiting |
| NCT04925752 | Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV… | Pre-Exposure Prophylaxis of HIV Infection | Active, Not Recruiting |
| NCT01651403 | Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil… | Chronic Hepatitis B | Active, Not Recruiting |
| NCT05502237 | Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT04639986 | Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer… | Metastatic Breast Cancer | Active, Not Recruiting |
| NCT05382299 | Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients… | Triple Negative Breast Cancer | Active, Not Recruiting |
| NCT05605899 | Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line… | High-risk Large B-cell Lymphoma (LBCL) | Active, Not Recruiting |
| NCT06630286 | Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With… | HIV-1-infection | Active, Not Recruiting |
| NCT03301506 | Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) | Primary Biliary Cirrhosis | Active, Not Recruiting |
| NCT02842086 | Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide… | Pre-Exposure Prophylaxis of HIV-1 Infection | Active, Not Recruiting |
| NCT05089734 | Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT06630299 | Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in… | HIV-1-Infection | Active, Not Recruiting |
| NCT06333808 | Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who… | HIV-1-infection | Active, Not Recruiting |
| NCT07047716 | Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) | HIV Pre-exposure Prophylaxis | Active, Not Recruiting |
| NCT06413498 | A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants… | Multiple Myeloma | Active, Not Recruiting |
| NCT06486441 | Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants… | Endometrial Cancer | Active, Not Recruiting |